These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 22142053

  • 1. Posttransplant lymphoproliferative disorder with lung involvement in a renal transplant recipient.
    Mirza EI, Mutluay R, Suyani E, Okyay GU, Akyurek N, Aki SZ, Derici U, Arinsoy T.
    Exp Clin Transplant; 2011 Dec; 9(6):425-8. PubMed ID: 22142053
    [Abstract] [Full Text] [Related]

  • 2. Posttransplant lymphoproliferative disorder after liver and kidney transplant.
    Akar Özkan E, Özdemir BH, Deniz EE, Tunca MZ, Haberal M.
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():142-8. PubMed ID: 24635813
    [Abstract] [Full Text] [Related]

  • 3. Brain tumor as an unusual presentation of posttransplant lymphoproliferative disorder.
    Azarpira N, Torabineghad S, Rakei M.
    Exp Clin Transplant; 2009 Mar; 7(1):58-61. PubMed ID: 19364315
    [Abstract] [Full Text] [Related]

  • 4. Detection of Epstein-Barr virus DNA in sequential renal transplant biopsy specimens using the polymerase chain reaction. Report of a patient with a posttransplant lymphoproliferative disorder.
    Lager DJ, Slagel DD, Burgart LJ.
    Arch Pathol Lab Med; 1993 Mar; 117(3):308-12. PubMed ID: 8382918
    [Abstract] [Full Text] [Related]

  • 5. Multifocal cranial plasmablastic lymphoma as a rare manifestation of posttransplant lymphoproliferative disorder.
    Jenabi A, Mooraki A, Jabbari M, Shayanfar N, Ghods AJ, Ziari MB, Bastani B.
    Iran J Kidney Dis; 2012 Sep; 6(5):380-5. PubMed ID: 22976265
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Epstein-Barr virus-associated lymphoproliferative disease in oral cavity in a renal transplant recipient: a case report.
    Johnson J, Kerecuk L, Harrison M, Taylor JO, Odell E.
    Pediatr Transplant; 2007 May; 11(3):340-4. PubMed ID: 17430495
    [Abstract] [Full Text] [Related]

  • 10. Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.
    Gulley ML, Swinnen LJ, Plaisance KT, Schnell C, Grogan TM, Schneider BG, Southwest Oncology Group.
    Transplantation; 2003 Sep 27; 76(6):959-64. PubMed ID: 14508361
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Novel treatment with rituximab of oropharyngeal posttransplant lymphoproliferative disorder after heart transplantation.
    Kaczmarek I, Beiras-Fernandez A, Sadoni S, Bengel D, Deutsch MA, Meiser B, Reichart B.
    Exp Clin Transplant; 2005 Dec 27; 3(2):381-4. PubMed ID: 16417448
    [Abstract] [Full Text] [Related]

  • 13. Subacute immune response to primary EBV infection leading to post-transplant lymphoproliferative disease in a renal transplant patient.
    Leaver S, Amlot P, Thuraisingham R, Norton A, Aitken C, Cavenagh JD.
    Clin Lab Haematol; 2004 Oct 27; 26(5):351-3. PubMed ID: 15485466
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Recurrent posttransplant lymphoproliferative disorder involving the larynx and trachea: case report and review of the literature.
    Banks CA, Meier JD, Stallworth CR, White DR.
    Ann Otol Rhinol Laryngol; 2012 May 27; 121(5):291-5. PubMed ID: 22724273
    [Abstract] [Full Text] [Related]

  • 17. Posttransplant lymphoproliferative disorder: a pictorial review.
    Burney K, Bradley M, Buckley A, Lyburn I, Rye A, Hopkins R.
    Australas Radiol; 2006 Oct 27; 50(5):412-8. PubMed ID: 16981935
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Posttransplant lymphoproliferative disorder in pediatric bone marrow transplant recipients: disseminated disease of donor origin demonstrated by fluorescence in situ hybridization.
    Lones MA, Lopez-Terrada D, Shintaku IP, Rosenthal J, Said JW.
    Arch Pathol Lab Med; 1998 Aug 27; 122(8):708-14. PubMed ID: 9701332
    [Abstract] [Full Text] [Related]

  • 20. Case report: successful treatment of posttransplant lymphoproliferative disorder and quiescence of dermatomyositis with rituximab and sirolimus.
    Kaposztas Z, Etheridge WB, Kahan BD.
    Transplant Proc; 2008 Jun 27; 40(5):1744-6. PubMed ID: 18589184
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.